Longeveron- Tradeable Rights - August 2023 Net Tangible Assets

The latest net tangible assets for LGVNR is $10M as of June 2026. That compares with $13M in the prior-year period — down 17.8% year over year. Investors often review this figure alongside Longeveron- Tradeable Rights - August 2023's historical trend and sector peers before judging valuation or financial health.

Over the past year, LGVNR's net tangible assets moved from $13M to $10M — a 17.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Longeveron- Tradeable Rights - August 2023's operating scale or balance-sheet position.

A net tangible assets figure of $10M for LGVNR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LGVNR's net tangible assets ($10M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Longeveron- Tradeable Rights - August 2023's net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.